Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04680130
Status
Enrolling By Invitation

Conditions

  • Apraxia of Speech
  • Behavioral Variant of Frontotemporal Dementia
  • CBD
  • FTD
  • LPA
  • MSA - Multiple System Atrophy
  • PCA
  • PPA
  • PSP
  • Parkinson Disease
  • Semantic Aphasia
  • Semantic Dementia

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • C-11 PiB — DRUG
    Completing PET scan looking for amyloid protein
  • AV1451 Tau — DRUG
    Completing PET scan looking for tau protein
  • C-11 ER176 — DRUG
    Completing PET scan looking for neuroinflammation

Study Details

The investigators aim to learn more about symptoms suggestive of a neurodegenerative process.

Key Dates

First listed
Dec 22, 2020
Start date
Nov 1, 2020
Status verified
Nov 2025
Primary completion
Nov 30, 2050
Completion
Nov 30, 2050

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Neurodegenerative symptoms

Primary Outcome Measure

Imaging analysis [ Time Frame: 1 year ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-

Find similar trials in Rochester, MN

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Mayo Clinic· Rochester, MN

Related Studies